A novel anti-cancer drug carrier, mesenchymal stem cells (MSCs) encapsulating drug-loaded hollow silica nanoparticles, is used to carry a photosensitizer drug and deliver it to breast tumors, due to the natural high tumor affinity of the MSCs, and inhibit tumor growth by photo dynamic therapy. This new strategy for delivering a photo sensitizer to tumors by using tumor-affinitive MSCs addresses the challenge of the accumulation of photosensitizer drugs in tumors in photodynamic therapy.
Keywords: cancer; mesenchymal stem cells (MSCs); nanoparticles; photodynamic therapy; photosensitizers.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.